REGENERON PHARMACEUTICALS, INC. Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 487.01 | 2,557 | 1,245,287 | 23,880,537 | 23.9 M to 23.9 M (+0.01 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 485.99 | 2,681 | 1,302,950 | 23,877,980 | 23.9 M to 23.9 M (+0.01 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 485.28 | 5,723 | 2,777,256 | 23,875,299 | 23.9 M to 23.9 M (+0.02 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 484.21 | 2,000 | 968,420 | 23,869,576 | 23.9 M to 23.9 M (+0.01 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 482.87 | 4,485 | 2,165,687 | 23,867,576 | 23.9 M to 23.9 M (+0.02 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 481.63 | 1,302 | 627,080 | 23,863,091 | 23.9 M to 23.9 M (+0.01 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 480.75 | 21,360 | 10,268,797 | 23,861,789 | 23.8 M to 23.9 M (+0.09 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 479.93 | 28,586 | 13,719,316 | 23,840,429 | 23.8 M to 23.8 M (+0.12 %) | |
| Aug 29 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 479.19 | 3,684 | 1,765,340 | 23,811,843 | 23.8 M to 23.8 M (+0.02 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 488.57 | 6,960 | 3,400,475 | 23,808,159 | 23.8 M to 23.8 M (+0.03 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 487.55 | 8,860 | 4,319,721 | 23,801,199 | 23.8 M to 23.8 M (+0.04 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 486.63 | 6,920 | 3,367,455 | 23,792,339 | 23.8 M to 23.8 M (+0.03 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 485.55 | 5,724 | 2,779,309 | 23,785,419 | 23.8 M to 23.8 M (+0.02 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 484.27 | 8,982 | 4,349,687 | 23,779,695 | 23.8 M to 23.8 M (+0.04 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 483.31 | 5,016 | 2,424,296 | 23,770,713 | 23.8 M to 23.8 M (+0.02 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 481.96 | 1,700 | 819,326 | 23,765,697 | 23.8 M to 23.8 M (+0.01 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 481.33 | 17,756 | 8,546,437 | 23,763,997 | 23.7 M to 23.8 M (+0.07 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 480.36 | 13,638 | 6,551,208 | 23,746,241 | 23.7 M to 23.7 M (+0.06 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 479.24 | 8,273 | 3,964,710 | 23,732,603 | 23.7 M to 23.7 M (+0.03 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 478.12 | 3,326 | 1,590,217 | 23,724,330 | 23.7 M to 23.7 M (+0.01 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 477.42 | 10,929 | 5,217,749 | 23,721,004 | 23.7 M to 23.7 M (+0.05 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 475.93 | 5,103 | 2,428,680 | 23,710,075 | 23.7 M to 23.7 M (+0.02 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 474.86 | 2,633 | 1,250,301 | 23,704,972 | 23.7 M to 23.7 M (+0.01 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 480.37 | 13,037 | 6,262,624 | 23,702,339 | 23.7 M to 23.7 M (+0.06 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 479.45 | 23,872 | 11,445,454 | 23,689,302 | 23.7 M to 23.7 M (+0.10 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 478.34 | 12,186 | 5,829,078 | 23,665,430 | 23.7 M to 23.7 M (+0.05 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 477.35 | 9,600 | 4,582,545 | 23,653,244 | 23.6 M to 23.7 M (+0.04 %) | |
| Aug 25 2017 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 475.97 | 1,900 | 904,349 | 23,643,644 | 23.6 M to 23.6 M (+0.01 %) | |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | M | 272.70 | 2,000 | 545,400 | 62,000 | |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 478.61 | 100 | 47,861 | 7,099 | 7.2 K to 7.1 K (-1.39 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 477.10 | 168 | 80,153 | 7,199 | 7.4 K to 7.2 K (-2.28 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 475.53 | 100 | 47,553 | 7,367 | 7.5 K to 7.4 K (-1.34 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 474.14 | 100 | 47,414 | 7,467 | 7.6 K to 7.5 K (-1.32 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 476.10 | 388 | 184,727 | 7,567 | 8 K to 7.6 K (-4.88 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 476.10 | 1,144 | 544,658 | 7,955 | 9.1 K to 8 K (-12.57 %) |
| Aug 24 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Buy | M | 272.70 | 2,000 | 545,400 | 9,099 | 7.1 K to 9.1 K (+28.17 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 483.00 | 106 | 51,198 | 329,543 | 329.6 K to 329.5 K (-0.03 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 482.72 | 400 | 193,088 | 329,649 | 330 K to 329.6 K (-0.12 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 481.37 | 4,661 | 2,243,666 | 330,049 | 334.7 K to 330 K (-1.39 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 480.62 | 5,250 | 2,523,255 | 334,710 | 340 K to 334.7 K (-1.54 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 479.63 | 600 | 287,778 | 339,960 | 340.6 K to 340 K (-0.18 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 478.51 | 1,600 | 765,616 | 340,560 | 342.2 K to 340.6 K (-0.47 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 477.52 | 3,473 | 1,658,427 | 342,160 | 345.6 K to 342.2 K (-1.00 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 476.46 | 5,744 | 2,736,786 | 345,633 | 351.4 K to 345.6 K (-1.63 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 475.49 | 5,610 | 2,667,499 | 351,377 | 357 K to 351.4 K (-1.57 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 474.64 | 2,400 | 1,139,136 | 356,987 | 359.4 K to 357 K (-0.67 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 473.65 | 200 | 94,730 | 359,387 | 359.6 K to 359.4 K (-0.06 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 472.67 | 900 | 425,403 | 359,587 | 360.5 K to 359.6 K (-0.25 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 471.63 | 600 | 282,978 | 360,487 | 361.1 K to 360.5 K (-0.17 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 470.64 | 400 | 188,256 | 361,087 | 361.5 K to 361.1 K (-0.11 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 472.16 | 200 | 94,432 | 361,487 | 361.7 K to 361.5 K (-0.06 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 471.09 | 1,951 | 919,097 | 361,687 | 363.6 K to 361.7 K (-0.54 %) |
| Aug 23 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 470.23 | 22,118 | 10,400,547 | 363,638 | 385.8 K to 363.6 K (-5.73 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.92 | 153,969 | 3,375,000 | 153,969 | |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 422 | 0 | 150,285 | 150.7 K to 150.3 K (-0.28 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 470.15 | 2,900 | 1,363,435 | 385,756 | 388.7 K to 385.8 K (-0.75 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 470.00 | 1,305 | 613,350 | 388,656 | 390 K to 388.7 K (-0.33 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 470.17 | 10,986 | 5,165,288 | 389,961 | 400.9 K to 390 K (-2.74 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 471.41 | 75,406 | 35,547,142 | 400,947 | 476.4 K to 400.9 K (-15.83 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 471.41 | 7,159 | 3,374,824 | 476,353 | 483.5 K to 476.4 K (-1.48 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.92 | 153,969 | 3,375,000 | 483,512 | 329.5 K to 483.5 K (+46.72 %) |
| Aug 18 2017 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 84,613 | 0 | 329,543 | 414.2 K to 329.5 K (-20.43 %) |
| Aug 11 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
| Aug 11 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Buy | M | 52.03 | 1,921 | 99,950 | 25,214 | 23.3 K to 25.2 K (+8.25 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | M | 272.70 | 2,000 | 545,400 | 64,000 | |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 473.57 | 226 | 107,027 | 7,099 | 7.3 K to 7.1 K (-3.09 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 472.54 | 100 | 47,254 | 7,325 | 7.4 K to 7.3 K (-1.35 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 471.00 | 100 | 47,100 | 7,425 | 7.5 K to 7.4 K (-1.33 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Sell | S | 469.91 | 100 | 46,991 | 7,525 | 7.6 K to 7.5 K (-1.31 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 466.98 | 307 | 143,363 | 7,625 | 7.9 K to 7.6 K (-3.87 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Payment of Exercise | F | 466.98 | 1,167 | 544,966 | 7,932 | 9.1 K to 7.9 K (-12.83 %) |
| Aug 09 2017 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Buy | M | 272.70 | 2,000 | 545,400 | 9,099 | 7.1 K to 9.1 K (+28.17 %) |